Sign In
Buy MIRM
$105.95
-6.64 (-5.90%)
At Close: Jul 31, 2026
TORONTO--(BUSINESS WIRE)--Mirum Announces Health Canada Authorization of LIVMARLI® Tablet Formulation for the Treatment of Cholestatic Pruritus in Alagille Syndrome.
TORONTO--(BUSINESS WIRE)--Health Canada Authorizes Mirum's LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis.
Is Mirum Pharmaceuticals on a Strong Path to Profitability?
03:02pm, Saturday, 31'st Jan 2026
Mirum Pharmaceuticals was profitable in the third quarter. However, top-line growth for the midcap biotech will slow this year.
Mirum Pharmaceuticals (NASDAQ:MIRM) COO Peter Radovich Sells 3,143 Shares of Stock
06:20am, Wednesday, 28'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) COO Peter Radovich sold 3,143 shares of the firm's stock in a transaction that occurred on Monday, January 26th. The stock was sold at an a
Mirum Pharmaceuticals (NASDAQ:MIRM) CEO Christopher Peetz Sells 6,831 Shares of Stock
06:20am, Wednesday, 28'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) CEO Christopher Peetz sold 6,831 shares of the business's stock in a transaction on Monday, January 26th. The shares were sold at an averag
Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Eric Bjerkholt Sells 1,053 Shares of Stock
06:20am, Wednesday, 28'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) CFO Eric Bjerkholt sold 1,053 shares of the company's stock in a transaction that occurred on Monday, January 26th. The shares were sold at
Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Jolanda Howe Sells 842 Shares
06:20am, Wednesday, 28'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) SVP Jolanda Howe sold 842 shares of the firm's stock in a transaction that occurred on Monday, January 26th. The stock was sold at an avera
Mirum Pharmaceuticals (NASDAQ:MIRM) Director Patrick Heron Purchases 131,425 Shares of Stock
05:35am, Wednesday, 28'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) Director Patrick Heron purchased 131,425 shares of the firm's stock in a transaction on Friday, January 23rd. The stock was bought at an av
Market Today: Fed Hold Looms; UPS Cuts, Amazon Grocery Shift
05:35pm, Tuesday, 27'th Jan 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in HIFS by 5.13%Add in DSP by 72.29%New position in ANDGStock News Social media addiction
Is Mirum Pharmaceuticals About to Soar in 2026?
02:55am, Tuesday, 27'th Jan 2026
Mirum Pharmaceuticals is at an inflection point. The company's sales are growing fast, led by the success of Livmarli.
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
08:00am, Monday, 26'th Jan 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease.
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Sells $86,423.58 in Stock
05:22am, Monday, 26'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) SVP Jolanda Howe sold 926 shares of the company's stock in a transaction dated Thursday, January 22nd. The stock was sold at an average pri
Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells $132,621.93 in Stock
05:22am, Monday, 26'th Jan 2026
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM - Get Free Report) CFO Eric Bjerkholt sold 1,421 shares of Mirum Pharmaceuticals stock in a transaction on Thursday, January 22nd. The shares were sold at an
Mirum Pharmaceuticals, Inc. $MIRM Shares Acquired by Emerald Advisers LLC
04:51am, Thursday, 22'nd Jan 2026
Emerald Advisers LLC increased its stake in shares of Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) by 20.9% during the undefined quarter, according to its most recent filing with the Securities and Exch
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy?
10:40am, Tuesday, 20'th Jan 2026
CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their growth.
